CD8A and neoplasm: The STING pathway, activated by IFN genes, is also activated in dendritic cells and promotes anti-tumor CD8+ T-cells in tumor-draining lymph nodes (TLDNs), which play a critical role in T-cell stimulation by concentrating tumor antigens [11].